Risks of sedating horses
Do not use DORMOSEDAN GEL in horses with cardiovascular disease, respiratory disorders, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold, fatigue, or high altitude. As with all alpha-adrenoceptor agonists, the potential for isolated cases of hypersensitivity, including paradoxical response (excitation), exists.DORMOSEDAN GEL has not been evaluated in ponies, miniature horses, or horses younger than one year of age.Accidental exposure could cause adverse reactions, including sedation, hypotension, and bradycardia.Seek medical attention immediately but do not drive because sedation or changes in blood pressure may occur.To report adverse reactions in users or to obtain a copy of the MSDS for this product call 1-888-963-8471.Note to physician: This product contains an alpha-adrenoceptor agonist. Do not use with other sedative drugs because the effects may be additive. The use of an alpha-agonist reversal agent with DORMOSEDAN GEL has not been evaluated.Individuals with cardiovascular disease (for example, hypertension or ischemic heart disease) should take special precautions to avoid exposure to this product.Caution should be exercised when handling sedated horses.
When the product is administered, the animal should be allowed to rest in a quiet place for a minimum of 40 minutes.
Withhold food and water until the sedative effects of the product wear off.
DORMOSEDAN GEL is contraindicated in horses with known hypersensitivity to detomidine.
Depress the plunger until the ring-stop contacts the barrel, depositing the product beneath the tongue.
The following picture demonstrates correct administration of DORMOSEDAN GEL beneath the tongue.